ADMA BIOLOGICS, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ADMA Biologics, Inc. on June 6, 2019. The filing pertains to upcoming investor presentations scheduled for June 2019.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate events rather than financial performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing serves to announce scheduled communications with the investment community.
Guidance, Outlook, and Management Commentary
Management has announced the following upcoming events:
- Jefferies 2019 Healthcare Conference: Scheduled for Thursday, June 6, 2019, in New York, NY.
- Raymond James Life Sciences and MedTech Conference: Scheduled for Wednesday, June 19, 2019, at 10:20 AM ET in New York, NY.
Adam Grossman (President and CEO) and Brian Lenz (Executive Vice President and CFO) will present at these events. The presentations will be webcast live via the company's website, and presentation slides are filed as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the live webcast availability on the company's Investor Relations page.
- Review the attached presentation slides (Exhibit 99.1) for specific operational updates or strategic guidance.
- Confirm the exact timing of the Raymond James presentation (10:20 AM ET).